These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
9. The role of adjuvant chemotherapy in locally advanced bladder cancer. Haque W; Lewis GD; Verma V; Darcourt JG; Butler EB; Teh BS Acta Oncol; 2018 Apr; 57(4):509-515. PubMed ID: 29226744 [TBL] [Abstract][Full Text] [Related]
10. Omission of radiation therapy following breast conservation in older (≥70 years) women with T1-2N0 triple-negative breast cancer. Haque W; Verma V; Hsiao KY; Hatch S; Arentz C; Szeja S; Schwartz M; Niravath P; Bonefas E; Miltenburg D; Brian Butler E; Teh BS Breast J; 2019 Nov; 25(6):1126-1133. PubMed ID: 31273872 [TBL] [Abstract][Full Text] [Related]
11. Narrow excision margins are appropriate for Merkel cell carcinoma when combined with adjuvant radiation: Analysis of 188 cases of localized disease and proposed management algorithm. Tarabadkar ES; Fu T; Lachance K; Hippe DS; Pulliam T; Thomas H; Li JY; Lewis CW; Doolittle-Amieva C; Byrd DR; Kampp JT; Parvathaneni U; Nghiem P J Am Acad Dermatol; 2021 Feb; 84(2):340-347. PubMed ID: 32711093 [TBL] [Abstract][Full Text] [Related]
12. Survival Benefit of Guideline-Concordant Postoperative Radiation for Local Merkel Cell Carcinoma. Wong WG; Stahl K; Olecki EJ; Holguin RP; Pameijer C; Shen C J Surg Res; 2021 Oct; 266():168-179. PubMed ID: 34015514 [TBL] [Abstract][Full Text] [Related]
13. Surgery and adjuvant radiotherapy for cutaneous melanoma considered high-risk for local-regional recurrence. Mendenhall WM; Shaw C; Amdur RJ; Kirwan J; Morris CG; Werning JW Am J Otolaryngol; 2013; 34(4):320-2. PubMed ID: 23375588 [TBL] [Abstract][Full Text] [Related]
14. Association Between Surgical Margins Larger Than 1 cm and Overall Survival in Patients With Merkel Cell Carcinoma. Andruska N; Fischer-Valuck BW; Mahapatra L; Brenneman RJ; Gay HA; Thorstad WL; Fields RC; MacArthur KM; Baumann BC JAMA Dermatol; 2021 May; 157(5):540-548. PubMed ID: 33760021 [TBL] [Abstract][Full Text] [Related]
15. Sphincter-sparing local excision and hypofractionated radiation therapy for anorectal melanoma: a 20-year experience. Kelly P; Zagars GK; Cormier JN; Ross MI; Guadagnolo BA Cancer; 2011 Oct; 117(20):4747-55. PubMed ID: 21446049 [TBL] [Abstract][Full Text] [Related]
16. The role of adjuvant radiotherapy in the local management of desmoplastic melanoma. Guadagnolo BA; Prieto V; Weber R; Ross MI; Zagars GK Cancer; 2014 May; 120(9):1361-8. PubMed ID: 24142803 [TBL] [Abstract][Full Text] [Related]
17. Adjuvant bevacizumab for melanoma patients at high risk of recurrence: survival analysis of the AVAST-M trial. Corrie PG; Marshall A; Nathan PD; Lorigan P; Gore M; Tahir S; Faust G; Kelly CG; Marples M; Danson SJ; Marshall E; Houston SJ; Board RE; Waterston AM; Nobes JP; Harries M; Kumar S; Goodman A; Dalgleish A; Martin-Clavijo A; Westwell S; Casasola R; Chao D; Maraveyas A; Patel PM; Ottensmeier CH; Farrugia D; Humphreys A; Eccles B; Young G; Barker EO; Harman C; Weiss M; Myers KA; Chhabra A; Rodwell SH; Dunn JA; Middleton MR; ; Nathan P; Lorigan P; Dziewulski P; Holikova S; Panwar U; Tahir S; Faust G; Thomas A; Corrie P; Sirohi B; Kelly C; Middleton M; Marples M; Danson S; Lester J; Marshall E; Ajaz M; Houston S; Board R; Eaton D; Waterston A; Nobes J; Loo S; Gray G; Stubbings H; Gore M; Harries M; Kumar S; Goodman A; Dalgleish A; Martin-Clavijo A; Marsden J; Westwell S; Casasola R; Chao D; Maraveyas A; Marshall E; Patel P; Ottensmeier C; Farrugia D; Humphreys A; Eccles B; Dega R; Herbert C; Price C; Brunt M; Scott-Brown M; Hamilton J; Hayward RL; Smyth J; Woodings P; Nayak N; Burrows L; Wolstenholme V; Wagstaff J; Nicolson M; Wilson A; Barlow C; Scrase C; Podd T; Gonzalez M; Stewart J; Highley M; Wolstenholme V; Grumett S; Goodman A; Talbot T; Nathan K; Coltart R; Gee B; Gore M; Farrugia D; Martin-Clavijo A; Marsden J; Price C; Farrugia D; Nathan K; Coltart R; Nathan K; Coltart R Ann Oncol; 2018 Aug; 29(8):1843-1852. PubMed ID: 30010756 [TBL] [Abstract][Full Text] [Related]
18. Roles of adjuvant and salvage radiotherapy for desmoplastic melanoma. Oliver DE; Patel KR; Switchenko J; Parker D; Lawson DH; Delman KA; Kudchadkar RR; Khan MK Melanoma Res; 2016 Feb; 26(1):35-41. PubMed ID: 26397051 [TBL] [Abstract][Full Text] [Related]
19. Stereotactic radiosurgery and immunotherapy in melanoma brain metastases: Patterns of care and treatment outcomes. Gabani P; Fischer-Valuck BW; Johanns TM; Hernandez-Aya LF; Keller JW; Rich KM; Kim AH; Dunn GP; Robinson CG; Chicoine MR; Huang J; Abraham CD Radiother Oncol; 2018 Aug; 128(2):266-273. PubMed ID: 29960685 [TBL] [Abstract][Full Text] [Related]
20. Long term follow up of the EORTC 18952 trial of adjuvant therapy in resected stage IIB-III cutaneous melanoma patients comparing intermediate doses of interferon-alpha-2b (IFN) with observation: Ulceration of primary is key determinant for IFN-sensitivity. Eggermont AM; Suciu S; Rutkowski P; Kruit WH; Punt CJ; Dummer R; Salès F; Keilholz U; de Schaetzen G; Testori A; Eur J Cancer; 2016 Mar; 55():111-21. PubMed ID: 26790144 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]